GT BIOPHARMA, INC. Notes Payable, Related Parties, Current
GT BIOPHARMA, INC. (GTBP) had Notes Payable, Related Parties, Current of $500.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes
us-gaap:NotesPayableRelatedPartiesClassifiedCurrent · last filed 2022-03-28
- 2021-12-31: Notes Payable, Related Parties, Current $500.00K.
- 2021-09-30: Notes Payable, Related Parties, Current $525.00K.
- 2021-06-30: Notes Payable, Related Parties, Current $525.00K.
- 2019-12-31: Notes Payable, Related Parties, Current $0.00.
| Period end | Notes Payable, Related Parties, Current |
|---|---|
| 2021-12-31 | $500.00K 10-K · filed 2022-03-28 |
| 2021-09-30 | $525.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $525.00K 10-Q/A · filed 2021-12-29 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-27 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2018-12-31 | $100.00K 10-K · filed 2020-03-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |